首页> 外国专利> herbal biologically active substance with polypharmacological effect

herbal biologically active substance with polypharmacological effect

机译:具有多种药理作用的草药生物活性物质

摘要

The invention relates to pharmacology and may be used to produce medicinal agents for treating and preventing viral diseases caused by herpes, influenza and hepatitis b and c viruses, as well as virus-induced immunodeficiencies. A biologically active substance having a polypharmacological effect is made from the green and spiky parts of cereals of the family gramineae, genus calamagrostis adans and / or genus deschampsia beauv, and contains flavonoids, specifically tricine, apigenin, luteoline, quercetin and ramnazine flavonoids aglycones. , and excipients, and has the following composition by weight percentage: flavonoid tricine aglycone and / or flavonoid tricine glycosides: 0.016 to 2.062%; flavonoid aglycone apigenin and / or flavonoid glycosides apigenin: 0.010 to 1.393% / flavonoid aglycone luteolin and / or flavonoid glycosides luteoline: 0.01 to 4.979%; flavonoid quercetin aglycone and / or quercetin flavonoid glycosides: 0.001 to 0.771%; flavonoid aglycone ramnazine and / or flavonoid glycosides ramnazine: 0.104 to 0.203%; excipients: 99,868 to 90,592%. Thus, the biologically active substance is enhanced by determining the specific compositions of its active ingredients, and the physical, chemical and biological characteristics thereof, resulting in the invention of an ideal composition (Figure 1) to achieve an antiviral effect against viruses. specific dosages when creating medicinal forms. In addition, it has been determined that the biologically active substance is an inducer of an endogenous ³-type interferon, has an apoptosis modulating effect, has antioxidant properties and increases free radical stress cell resistance. The antiviral effect for specific viruses has been established as an antiviral effect for herpes simplex virus type 2 and bovine viral diarrhea virus (hepatitis c virus).
机译:本发明涉及药理学,并且可以用于生产用于治疗和预防由疱疹,流感和乙型和丙型肝炎病毒以及病毒诱导的免疫缺陷引起的病毒性疾病的药物。具有多药理学作用的生物活性物质是由禾本科,蒲甘属和/或去皮甜美属的谷物的绿色和尖刺部分制得的,并且包含类黄酮,特别是曲辛,芹菜素,黄体碱,槲皮素和三嗪类黄酮苷元。 ,和赋形剂,并具有以下重量百分比组成:类黄酮三嗪糖苷和/或类黄酮三嗪糖苷:0.016至2.062%;类黄酮苷元芹菜素和/或类黄酮苷芹菜素:0.010至1.393%/类黄酮苷元木犀草素和/或类黄酮苷黄酮:0.01至4.979%;黄酮类槲皮素苷元和/或槲皮素类黄酮苷:0.001%至0.771%;类黄酮苷元雷马嗪和/或类黄酮苷雷那嗪:0.104至0.203%;辅料:99,868至90,592%。因此,通过确定其活性成分的具体组成及其物理,化学和生物学特性来增强生物活性物质,从而发明了理想的组合物(图1),以实现对病毒的抗病毒作用。制成药物形式时的特定剂量。另外,已确定该生物活性物质是内源性β-型干扰素的诱导剂,具有细胞凋亡调节作用,具有抗氧化特性并增加了自由基应激细胞的抗性。对特定病毒的抗病毒作用已被确定为对2型单纯疱疹病毒和牛病毒性腹泻病毒(丙型肝炎病毒)的抗病毒作用。

著录项

  • 公开/公告号BR112017021292A2

    专利类型

  • 公开/公告日2018-12-04

    原文格式PDF

  • 申请/专利权人 ANATOLLI NOVIK;VICTOR ATAMANIUK;

    申请/专利号BR20171121292

  • 发明设计人 VICTOR ATAMANIUK;

    申请日2015-10-28

  • 分类号A61K31/352;A61K36/899;A61P31/12;A61P37;A61P39/06;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号